|
|
||||||||
From the Department of Neurological Sciences (Dr. Del Brutto), HospitalClinica Kennedy, Guayaquil, Ecuador; the Department of Neurological Sciences (Dr. Rajshekhar), Christian Medical College and Hospital, Vellore, India; the Infectious Disease Section (Dr. White), Department of Medicine, Baylor College of Medicine, Houston, TX; the Division of Parasitic Diseases (Drs. Tsang and Schantz), National Center for Infectious Diseases, Centers for Disease Control, Atlanta, GA; the Laboratory of Parasitic Diseases (Dr. Nash), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; the Department of Neurology (Dr. Takayanagui), Faculty of Medicine of Ribeirao Preto, University of Sao Paolo, Brazil; the University of Cambridge Clinical School (Dr. Evans), Cambridge, UK; the Instituto de Diagnóstico y Referencia Epidemiológicos (Drs. Flisser and Correa) and Dirección General de Epidemiología (Dr. Sarti), Secretaría de Salud, Mexico DF, Mexico; the Instituto Colombiano de Medicina Tropical (Dr. Botero), Medellín, Colombia; Pfizer Global Research and Development (Dr. Allan), Sandwich, UK; the Universidad Nacional Mayor de San Marcos de Lima (Dr. Gonzalez), Perú; the Asociación Benéfica, Proyectos en Informática, Salud, Medicina y Agricultura (Drs. Gonzalez, Gilman, and García), Lima, Perú; the Department of International Health (Dr. Gilman), The Johns Hopkins University, School of Hygiene and Public Health, Baltimore, MD; and the Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, and the Departments of Microbiology and Pathology, Universidad Peruana Cayetano Heredia (Drs. Gilman and García), Lima, Perú.
Address correspondence and reprint requests to Dr. Oscar H. Del Brutto, Air Center 3542, PO Box 522970, Miami, FL 33152-2970; e-mail: odbrutto{at}telconet.net
Neurocysticercosis is the most common helminthic infection of the CNS but its diagnosis remains difficult. Clinical manifestations are nonspecific, most neuroimaging findings are not pathognomonic, and some serologic tests have low sensitivity and specificity. The authors provide diagnostic criteria for neurocysticercosis based on objective clinical, imaging, immunologic, and epidemiologic data. These include four categories of criteria stratified on the basis of their diagnostic strength, including the following: 1) absolutehistologic demonstration of the parasite from biopsy of a brain or spinal cord lesion, cystic lesions showing the scolex on CT or MRI, and direct visualization of subretinal parasites by funduscopic examination; 2) majorlesions highly suggestive of neurocysticercosis on neuroimaging studies, positive serum enzyme-linked immunoelectrotransfer blot for the detection of anticysticercal antibodies, resolution of intracranial cystic lesions after therapy with albendazole or praziquantel, and spontaneous resolution of small single enhancing lesions; 3) minorlesions compatible with neurocysticercosis on neuroimaging studies, clinical manifestations suggestive of neurocysticercosis, positive CSF enzyme-linked immunosorbent assay for detection of anticysticercal antibodies or cysticercal antigens, and cysticercosis outside the CNS; and 4) epidemiologicevidence of a household contact with Taenia solium infection, individuals coming from or living in an area where cysticercosis is endemic, and history of frequent travel to disease-endemic areas. Interpretation of these criteria permits two degrees of diagnostic certainty: 1) definitive diagnosis, in patients who have one absolute criterion or in those who have two major plus one minor and one epidemiologic criterion; and 2) probable diagnosis, in patients who have one major plus two minor criteria, in those who have one major plus one minor and one epidemiologic criterion, and in those who have three minor plus one epidemiologic criterion.
This article has been cited by other articles:
![]() |
T. Kadhiravan, M. Soneja, S. Hari, and S. K. Sharma Images in Clinical Tropical Medicine: Disseminated Cysticercosis Am J Trop Med Hyg, May 1, 2009; 80(5): 699 - 699. [Full Text] [PDF] |
||||
![]() |
C. Graeff-Teixeira, A. C. A. da Silva, and K. Yoshimura Update on Eosinophilic Meningoencephalitis and Its Clinical Relevance Clin. Microbiol. Rev., April 1, 2009; 22(2): 322 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bose, J. Chandran, and R. Cherian Multiple lesions on CT brain scan: tuberculosis or neurocysticercosis? BMJ Case Reports, March 19, 2009; 2009(jan27_1): bcr0620080155 - bcr0620080155. [Abstract] [Full Text] |
||||
![]() |
J. G. Burneo, I. Plener, H. H. Garcia, and Neurocysticercosis and Epilepsy Research Network Neurocysticercosis in a patient in Canada Can. Med. Assoc. J., March 17, 2009; 180(6): 639 - 642. [Full Text] [PDF] |
||||
![]() |
P. Martin-Davila, J. Fortun, R. Lopez-Velez, F. Norman, M. Montes de Oca, P. Zamarron, M. I. Gonzalez, A. Moreno, T. Pumarola, G. Garrido, et al. Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation Clin. Microbiol. Rev., January 1, 2008; 21(1): 60 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.K. Handique, R.R. Das, B. Saharia, P. Das, R. Buragohain, and P. Saikia Coinfection of Japanese Encephalitis with Neurocysticercosis: An Imaging Study AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 170 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.T. Lucato, M.S. Guedes, J.R. Sato, L.A. Bacheschi, L.R. Machado, and C.C. Leite The Role of Conventional MR Imaging Sequences in the Evaluation of Neurocysticercosis: Impact on Characterization of the Scolex and Lesion Burden AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1501 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A L Bastos, E Marchiori, E L Gasparetto, B H Andrade, G C Junior, R C Carvalho, D L Escuissato, and A S Souza, Pulmonary and cardiac cysticercosis: helical CT findings Br. J. Radiol., March 1, 2007; 80(951): e58 - e60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazumdar, P. Pandharipande, and A. Poduri Does Albendazole Affect Seizure Remission and Computed Tomography Response in Children With Neurocysticercosis? A Systematic Review and Meta-analysis J Child Neurol, February 1, 2007; 22(2): 135 - 142. [Abstract] [PDF] |
||||
![]() |
V. Rajshekhar, M. V. Raghava, V. Prabhakaran, A. Oommen, and J. Muliyil Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India Neurology, December 26, 2006; 67(12): 2135 - 2139. [Abstract] [Full Text] [PDF] |
||||
![]() |
Picture of the Month--Diagnosis Arch Pediatr Adolesc Med, October 1, 2006; 160(10): 1082 - 1083. [Full Text] [PDF] |
||||
![]() |
T R Velasco, P A Zanello, C L Dalmagro, D Araujo Jr, A C Santos, M M Bianchin, V Alexandre Jr, R Walz, J A Assirati, C G Carlotti Jr, et al. Calcified cysticercotic lesions and intractable epilepsy: a cross sectional study of 512 patients J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 485 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Thomas and T. Krishnamoorthy Extensive brain and muscular cysticercosis Neurology, February 14, 2006; 66(3): E13 - E13. [Full Text] [PDF] |
||||
![]() |
B. Thomas and T. Krishnamoorthy Migrating intraventricular cysticercus during MRI Neurology, October 25, 2005; 65(8): 1321 - 1321. [Full Text] [PDF] |
||||
![]() |
C. M. SCHEEL, A. KHAN, K. HANCOCK, H. H. GARCIA, A. E. GONZALEZ, R. H. GILMAN, V. C. W. TSANG, and THE CYSTICERCOSIS WORKING GROUP IN PERU SERODIAGNOSIS OF NEUROCYSTICERCOSIS USING SYNTHETIC 8-KD PROTEINS: COMPARISON OF ASSAY FORMATS Am J Trop Med Hyg, October 1, 2005; 73(4): 771 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
V C Terra-Bustamante, E R Coimbra, K O Rezek, S R Escorsi-Rosset, R Guarnieri, C L Dalmagro, L M Inuzuka, M M Bianchin, L Wichert-Ana, V Alexandre, et al. Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1080 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Ramirez-Bermudez, J Higuera, A L Sosa, E Lopez-Meza, M Lopez-Gomez, and T Corona Is dementia reversible in patients with neurocysticercosis? J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1164 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Gupta, K. M. Hasan, A. M. Mishra, D. Jha, M. Husain, K. N. Prasad, and P. A. Narayana High Fractional Anisotropy in Brain Abscesses versus Other Cystic Intracranial Lesions AJNR Am. J. Neuroradiol., May 1, 2005; 26(5): 1107 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. BUENO, C. M. SCHEEL, A. J. VAZ, L. R. MACHADO, J. A. LIVRAMENTO, O. M. TAKAYANAGUI, V. C. W. TSANG, and K. HANCOCK APPLICATION OF SYNTHETIC 8-KD AND RECOMBINANT GP50 ANTIGENS IN THE DIAGNOSIS OF NEUROCYSTICERCOSIS BY ENZYME-LINKED IMMUNOSORBENT ASSAY Am J Trop Med Hyg, March 1, 2005; 72(3): 278 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. GARCIA, O. H. DEL BRUTTO, T. E. NASH, A. C. WHITE JR., V. C. W. TSANG, and R. H. GILMAN NEW CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF NEUROCYSTICERCOSIS (TAENIA SOLIUM) Am J Trop Med Hyg, January 1, 2005; 72(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Wallin and J. F. Kurtzke Neurocysticercosis in the United States: Review of an important emerging infection Neurology, November 9, 2004; 63(9): 1559 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Singhi and S. Singhi Topical Review: Neurocysticercosis in Children J Child Neurol, July 1, 2004; 19(7): 482 - 492. [Abstract] [PDF] |
||||
![]() |
L. Wichert-Ana, T. R. Velasco, V. C. Terra-Bustamante, V. Alexandre Jr, R. Walz, M. M. Bianchin, J. P. Leite, J. A. Assirati, C. G. Carlotti, D. Araujo, et al. Surgical Treatment for Mesial Temporal Lobe Epilepsy in the Presence of Massive Calcified Neurocysticercosis Arch Neurol, July 1, 2004; 61(7): 1117 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Braga, A. J. Rocha, H. R. Gomes, G. H. Filho, C. J. Silva, and R. B. Fonseca Noninvasive MR Cisternography with Fluid-Attenuated Inversion Recovery and 100% Supplemental O2 in the Evaluation of Neurocysticercosis AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 295 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MEZA-LUCAS, L. CARMONA-MIRANDA, R. C. GARCIA-JERONIMO, A. TORRERO-MIRANDA, G. GONZALEZ-HIDALGO, G. LOPEZ-CASTELLANOS, and D. CORREA SHORT REPORT: LIMITED AND SHORT-LASTING HUMORAL RESPONSE IN TAENIA SOLIUM: SEROPOSITIVE HOUSEHOLDS COMPARED WITH PATIENTS WITH NEUROCYSTICERCOSIS Am J Trop Med Hyg, August 1, 2003; 69(2): 223 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Azad, R K Gupta, S Kumar, C M Pandey, K N Prasad, N Husain, and M Husain Is neurocysticercosis a risk factor in coexistent intracranial disease? An MRI based study J. Neurol. Neurosurg. Psychiatry, March 1, 2003; 74(3): 359 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Garcia, C. A. W. Evans, T. E. Nash, O. M. Takayanagui, A. C. White Jr., D. Botero, V. Rajshekhar, V. C. W. Tsang, P. M. Schantz, J. C. Allan, et al. Current Consensus Guidelines for Treatment of Neurocysticercosis Clin. Microbiol. Rev., October 1, 2002; 15(4): 747 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Proano-Narvaez, A. Meza-Lucas, O. Mata-Ruiz, R. C. Garcia-Jeronimo, and D. Correa Laboratory Diagnosis of Human Neurocysticercosis: Double-Blind Comparison of Enzyme-Linked Immunosorbent Assay and Electroimmunotransfer Blot Assay J. Clin. Microbiol., June 1, 2002; 40(6): 2115 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Aguilar-Rebolledo, A. Meza-Lucas, J. Torres, R. Cedillo-Rivera, A. Enciso, R. C. Garcia, O. Munoz, and D. Correa Evaluation of the Enzyme-Linked Immunoelectrotransfer Blot Assay for Diagnosis of Neurocysticercosis in Children J Child Neurol, June 1, 2002; 17(6): 416 - 420. [Abstract] [PDF] |
||||
![]() |
R. K. Garg, M. K. Katti, and O. H. Del Brutto Proposed diagnostic criteria for neurocysticercosis Neurology, April 23, 2002; 58(8): 1315 - 1316. [Full Text] [PDF] |
||||
![]() |
R. K. Garg Visual loss in cysticercosis: Analysis of 23 patients Neurology, April 9, 2002; 58(7): 1133 - 1133. [Full Text] [PDF] |
||||
![]() |
Further Progress in Refining Diagnostic Criteria for Neurocysticercosis Journal Watch Neurology, October 5, 2001; 2001(1005): 8 - 8. [Full Text] |
||||
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |